“flu” Archives

in
Entry Author Date Location
WI Watchlist: FluGen, Propeller Health, Gener8tor, EnSync 02/15/19 Wisconsin
NIH Using Vaccines from Madison Startup FluGen in New Clinical Trial 09/19/18 Wisconsin
With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines 08/16/18 New York
Bright Cellars, AmFam, Coinigy & More: This Week’s WI Watchlist 05/18/18 Wisconsin
FluGen to Study Versatility of Its Universal Flu Vaccine Candidate 05/17/18 Wisconsin
FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge 05/01/18 Wisconsin
Exact Sciences: Severe Flu Season Slows Down Cancer Test’s Sales 02/26/18 Wisconsin
15 For ’18: Key Clinical Data to Watch For Next Year (Part 2) 12/06/17 National
Fresh Off New Funding Round, FluGen Plans 3 Clinical Trials for 2018 08/04/17 Wisconsin
Visterra, Braeburn Stumble After Solid ’17 Start for Bio IPOs 02/10/17 Boston
Flu Research, Propeller, & Stem Cells: This Week’s WI Watchlist 05/31/16 Wisconsin
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq 06/16/15 Boston
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
WI-based FluGen Raises $3.4M For Universal Flu Vaccine Phase I Trial 06/02/14 Wisconsin
Myriad RBM Test Helping to Mine Secrets of Normal Immune System 04/16/14 Texas
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests 01/30/14 Wisconsin
Theraclone Merges With PharmAthene, Plans to Stay in Seattle 08/01/13 Seattle
East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health 03/15/13 Boston
IDRI, Medicago To Test Self-Injectable Pandemic Flu Vaccine 08/16/12 Seattle
Theraclone Takes 2nd Antibody into the Clinic Against Common Virus 06/14/12 Seattle
Theraclone Passes First Clinical Test with Flu-Fighting Antibody 05/15/12 Seattle
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO 12/06/11 Seattle
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News 09/22/11 Seattle
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic 09/21/11 Seattle
NYC’s Vivaldi, Allied With Harvard and San Francisco VC Firm, Forge a New Way to Fight the Flu 04/28/11 New York
VBI Progressing with Vaccines That Don’t Require Refrigeration 03/24/11 Boston
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies 03/08/11 Seattle
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
Page 1 of 3 next page »